Business Wire

Preclinical Studies From Vaxxas and Collaborators Reveal Potential of Vaxxas’ Novel High-Density Microarray Patch (HD-MAP) to Effectively Deliver SARS-CoV-2 Spike Vaccine

CAMBRIDGE, Mass. & BRISBANE, Australia--(BUSINESS WIRE)--Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced that research demonstrating the ...
Medical Xpress

Microarray patches safe and effective for vaccinating children, trial shows

A Phase I/II randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...
The Scientist

A Personal Microarray Scribe

Foot soldiers in the "Omics revolution" have an ally in the BioOdyssey Calligrapher MiniArrayer, a new entry into the benchtop microarray printing arena from Bio-Rad Laboratories. The $25,000 (US) ...
Business Wire

Vaxxas Initiates Phase I Clinical Trial of Pre-Pandemic Avian Influenza A Virus (H7N9) Vaccine Delivered Using Vaxxas’ Novel High-Density Microarray Patch (HD-MAP)

Multi-center Phase I clinical study will evaluate the safety and tolerability of a monovalent strain of avian influenza A (H7N9) vaccine delivered intradermally by Vaxxas’ high-density microarray ...
ascopubs.org

Can gene expression microarray (GEM) provide a diagnosis in cases of carcinoma of unknown primary?

A study of US-based Indian and Pakistani population with cancer diagnosis reported in the SEER database from 1988 to 2002 Patients with CUP constitute approximately 5% of all malignancies and have no ...
ascopubs.org

A novel cellular microarray identifies functional deficiencies in tumor-specific T cell responses

Randomised, double blind, placebo-controlled, multi-centre, group-sequential trial of G17DT for patients with advanced pancreatic cancer unsuitable or unwilling to take chemotherapy No significant ...